SCHEMBL2511248

SCHEMBL2511248

S=C1Nc2ccccc2Nc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
ACVR1 Q04771 2/20 0.54
LRRK2 Q5S007 2/20 0.54
PDGFRA P16234 1/20 0.54
FER P16591 1/20 0.54
LTK P29376 1/20 0.54
CDK8 P49336 1/20 0.54
DYRK1B Q9Y463 1/20 0.54
KDM4E B2RXH2 3/20 0.47
RXFP1 Q9HBX9 1/20 0.46
MAOA P21397 2/20 0.43
MAOB P27338 1/20 0.43
CSNK1G1 Q9HCP0 1/20 0.40
CHEK1 O14757 1/20 0.40
MAPT P10636 3/20 0.39
GAA P10253 2/20 0.39
ROS1 P08922 1/20 0.38
CDK5 Q00535 1/20 0.38
CHRM1 P11229 1/20 0.38
MEN1 O00255 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12683716 0.95 ALDH1A1 (0.59) ALDH1A1ACVR1LRRK2PDGFRAFER
SCHEMBL2643929 0.95
SCHEMBL8230577 0.83 CHEK1 (0.66) ALDH1A1ACVR1LRRK2PDGFRAFER
SCHEMBL11878147 0.83 CHEK1 (0.66) ALDH1A1ACVR1LRRK2PDGFRAFER
SCHEMBL8889856 0.83 CSNK1G1 (0.66) ALDH1A1ACVR1LRRK2PDGFRAFER
SCHEMBL3077372 0.80 ALDH1A1 (0.50) ALDH1A1ACVR1LRRK2PDGFRAFER
SCHEMBL11878670 0.79 MAPT (0.49) ALDH1A1LRRK2KDM4ECSNK1G1CHEK1
SCHEMBL11880410 0.79 NOX1 (0.49) ALDH1A1ACVR1LRRK2PDGFRAFER
SCHEMBL11877335 0.79 CSNK1G1 (0.42) ALDH1A1ACVR1LRRK2PDGFRAFER
SCHEMBL8890624 0.79 MAPT (0.49) ALDH1A1LRRK2KDM4ECSNK1G1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8541407-B2 Substituted benzo-pyrido-triazolo-diazepine compounds ARQULE, INC. (US) 2013-09-24 US disclosed
US-8541407-B2 Substituted benzo-pyrido-triazolo-diazepine compounds ARQULE, INC. (US) 2013-09-24 US disclosed
WO-2011123678-A2 SUBSTITUTED BENZO-PYRIDO-TRIAZOLO-DIAZEPINE COMPOUNDS ARQULE, INC. (US) 2011-10-06 WO disclosed
WO-2011123678-A2 SUBSTITUTED BENZO-PYRIDO-TRIAZOLO-DIAZEPINE COMPOUNDS ARQULE, INC. (US) 2011-10-06 WO disclosed
US-20110245236-A1 Substituted Benzo-Pyrido-Triazolo-Diazepine Compounds ARQULE, INC. (US) 2011-10-06 US disclosed
US-20110245236-A1 Substituted Benzo-Pyrido-Triazolo-Diazepine Compounds ARQULE, INC. (US) 2011-10-06 US disclosed
WO-1997000252-A1 TRICYCLIC INHIBITORS OF PROTEIN FARNESYLTRANSFERASE WARNER-LAMBERT COMPANY (US) 1997-01-03 WO disclosed
US-3956297-A 9H-Dibenzo[b,f]imidazo[1,2-d][1,4]diazepines THE UPJOHN COMPANY (US) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245236-A1 Substituted Benzo-Pyrido-Triazolo-Diazepine Compounds BRD4, PDXK, THPO ALDH1A1 1709/4885ACVR1 3447/4885LRRK2 2277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.